MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

Leveraging the Third Amendment Ruling the Risk Management Process: Frost & Sullivan's Assessment of Regulations for Medical Imaging Equipment in Europe

— LONDON, March 25

LONDON, March 25 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the European Medical Imaging Equipment Market to be held on Wednesday, 1st April 2009, at 4 p.m. GMT.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

In 2006 the third amendment of the electrical equipment safety standard was introduced, requiring that manufacturers of electro-medical equipment have a formal risk management process. The Frost & Sullivan analyst briefing will present an overview of this legal demand and discuss and analyze the impact it has on imaging modality manufacturers as well as regulatory authorities.

Any manufacturer of medical imaging equipment will benefit from this briefing. Regulations are continuously improvised in Europe, and manufacturers can leverage the risk management by reviewing its fundamental requirements.

"Imaging equipment manufacturers now have the liberty to customize standards to the needs of the device," concludes Research Analyst Sriram Shanmugham.

Frost & Sullivan will hold this conference call at 4 p.m. GMT on Wednesday, 1st April 2009, which will provide industry participants an outlook of the Regulations for European Medical Imaging Equipment. To participate, please email Katja Feick at katja.feick@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you.

GIL 2009: Europe

Frost & Sullivan has expanded its flagship Global Congress on Corporate Growth - GIL Global - into several major cities around the world including London. For the first time ever in Europe, Frost & Sullivan will be hosting the Growth, Innovation and Leadership Congress 'GIL 2009: Europe' on 19-20 May, at the Sofitel St James in London. GIL Global is the industry's only event designed to support senior executives in their efforts to achieve sustainable, top-line growth. To register, obtain a programme agenda, explore sponsorship opportunities, or attend as a member of the media for GIL 2009: Europe, please contact Katja Feick, Corporate Communications Europe, at katja.feick@frost.com. One-on-One interviews with Frost & Sullivan senior growth consultants are also being scheduled. For more information you can also visit http://www.frost.com/gilglobal

About Frost & Sullivan:

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com/

Contact: Katja Feick Corporate Communications - Europe P: +49-(0)-69-77-0-33-43 F: +49-(0)-69-23-45-66 E: katja.feick@frost.com www.frost.com

Related news

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us